ADITXT INC (ADTX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ADTX
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Elevated risk of a next-quarter earnings miss: this name is a smaller-cap name (higher miss base rate) and operates in a high-miss-rate industry. A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 399 industry peers · Company calendar date is not available
ADTX — divestiture
Dated 2026-08-19
Other Events. On August 12, 2026, Aditxt, Inc. (the “ Company ”) entered into a Stock Purchase Agreement (the “ Purchase Agreement ”) by and among the Company, MDNA Holdings Inc., a Florida corporation (“ Buyer ”), and the Company’s majority owned subsidiary, Pearsanta, Inc. (“ Pearsanta ”), pursuant to which Buyer acquired substantially all of the outstanding shares of Pearsanta (the “ Shares ”) at a closing that occurred on August 12, 2026 (the “ Closing ”). The consideration under the Purc…
Why it matters: Raising capital can help with cash flow and support growth. Investors will watch how well the company handles its money.
Supportive ifA press release says the company raised over $5 million.
Worry ifNot getting more funding or a big drop in cash reserves in upcoming reports.
Why it matters: Better compliance can stop delisting. It can also build investor trust.
Supportive ifThe company says it has solved its problems with Nasdaq.
Worry ifThe company gets more delisting notices or fails to meet deadlines.
Why it matters: This decision will determine if Aditxt can remain listed on Nasdaq. A positive outcome could stabilize the stock.
Watch forThe Listing Review Council changes its mind about the delisting.
Also watch forThe Listing Review Council keeps the delisting decision.
Why it matters: A new CEO might bring new ideas to solve problems and improve operations.
Supportive ifAnnouncement of a new CEO with relevant experience and a solid plan for the company.
Worry ifThe company may still lack a CEO or clear leadership.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$1,054 on $10,000 · ±10.5% | How much price usually moves either way. |
| Bad day | $3,339 loss on $10,000 · 33.4% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $10,000 loss on $10,000 · 100.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Checking Ignite's value at $150 million matters for Aditxt's money and plans.
Supportive ifThe deal with Copley Acquisition Corp. closes. This shows Ignite's $150 million value.
Worry ifThe business combination fails or Ignite's value drops a lot.
Why it matters: Updates on Ignite's sales efforts could show how well Aditxt is doing under new leaders.
Supportive ifAditxt shares news of big partnerships or revenue growth from Ignite.
Worry ifIgnite fails to secure new partnerships or shows stagnant revenue.
Why it matters: Recent exits of key leaders may affect the company's plans and work.
Watch forAppointment of a new CEO and General Counsel who can stabilize leadership.
Also watch forNo new leaders mean uncertainty for the company.
Why it matters: This merger is key to unlocking value for Aditxt and its shareholders.
Supportive ifThe business combination with Copley Acquisition Corp. is worth $150 million.
Worry ifThe business combination does not close by the target date.
Why it matters: The company has struggled with cash flow. Successful capital raising is critical for operations.
Supportive ifFinishing a new capital raise over $5M through loans or stock.
Worry ifFailure to raise any new capital in the next quarter.
Why it matters: The business combination could bring new growth chances, but success is not guaranteed.
Supportive ifThe business deal with Copley Acquisition Corp. is complete.
Worry ifEnding the business deal or big delays could happen.
Why it matters: The company may be removed from Nasdaq because of equity issues. This limits its ability to raise money.
Worry ifA public announcement shows that Nasdaq has changed its mind about delisting.
Less concerning ifMore notices of delisting or not meeting listing rules.
Why it matters: The decision will affect Aditxt's listing on Nasdaq. This impacts investor trust and funding.
Worry ifThe Nasdaq Listing and Hearing Review Council supports Aditxt's appeal to stay listed.
Less concerning ifThe Nasdaq council supports the decision to delist.
Why it matters: This meeting will address the business combination with Ignite. Approval is crucial for Aditxt's future.
Supportive ifShareholders agree to the deal with Ignite Proteomics.
Worry ifShareholders do not agree to the business deal with Ignite Proteomics.
Why it matters: This vote is critical for compliance with Nasdaq's bid price rule. It impacts Aditxt's market standing.
Supportive ifShareholders agree to the reverse stock split plan.
Worry ifShareholders do not agree to the reverse stock split plan.